+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Blood-based Biomarker For Parkinson's Disease Market Size, Share & Trends Analysis Report By Biomarker (Protein Biomarkers, Inflammatory Markers), By Technology (ELISA/Immunoassay, Multiplex platforms), By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 150 Pages
  • July 2025
  • Region: Global
  • Grand View Research
  • ID: 6154636
Description Jump to:

Blood-based Biomarker For Parkinson’s Disease Market Summary

The global blood-based biomarker for Parkinson’s disease market size was estimated at USD 117.79 million in 2024 and is projected to reach USD 350.87 million by 2033, growing at a CAGR of 19.25% from 2025 to 2033. The market is exhibiting significant growth driven by rising prevalence of Parkinson’s disease worldwide, increasing investment in neurology diagnostics and biomarker research and advances in proteomics and genomic technologies.

The data from the global burden of disease study 2021, researchers project that by 2050, Parkinson’s disease will affect approximately 25.2 million people worldwide across all ages and sexes, an increase of 112% compared to the numbers recorded in 2021. The global incidence of Parkinson’s disease (PD) is increasing due to geriatric populations, particularly in North America, Europe, and parts of Asia-Pacific. Parkinson’s disease (PD) incidence rates increase significantly with age, particularly among individuals aged 65 and older, making age the primary risk factor for the condition. Some studies consistently show that PD is more prevalent in males than females across all age groups. The rising incidence of PD closely correlates with the expanding aging population worldwide, suggesting that demographic shifts will continue to drive up the number of cases in the coming decades. As life expectancy increases, the burden of Parkinson’s disease is expected to grow. The graph below depicts cases of Parkinson’s disease in various continents according to the IHME Global Burden of Disease (2024):

This growing patient pool drives urgent demand for early, accurate and minimally invasive diagnostic tools. Blood-based biomarkers offer a promising alternative to traditional clinical and imaging-based diagnosis, which often detects PD only in later stages. As awareness of neurodegenerative diseases increases globally, so does the need for accessible diagnostics, positioning blood-based biomarkers as a critical solution to meet the rising burden of Parkinson’s and support earlier therapeutic intervention.

Blood-based Biomarker For Parkinson’s Disease Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the blood-based biomarker for Parkinson’s disease market report based on technology, biomarker, end use, and region:

Biomarker Outlook (Revenue, USD Million, 2021-2033)

  • Protein biomarkers
  • Inflammatory markers
  • Metabolic markers
  • Transcriptomic/miRNA
  • Others

Technology Outlook (Revenue, USD Million, 2021-2033)

  • ELISA/Immunoassay
  • Multiplex platforms
  • NGS/qPCR (genetic)
  • Mass spectrometry
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Academic/Research Labs
  • Pharmaceutical / Biotech (for Clinical Trials)
  • Hospitals
  • Clinical Diagnostic Labs
  • Others

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Blood-based Biomarker for Parkinson’s Disease Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of Parkinson’s disease worldwide
3.2.1.2. Increasing investment in neurology diagnostics and biomarker research
3.2.1.3. Advances in proteomics and genomic technologies
3.2.2. Market Restraint Analysis
3.2.2.1. High Costs and Technical Complexity Restrict Accessibility in Low-Resource Settings
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Blood-based Biomarker For Parkinson’s Disease Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Reimbursement Scenario
3.3.6. Technological Advancements
Chapter 4. Blood-based Biomarker for Parkinson’s Disease Market: Biomarker Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Blood-based Biomarker For Parkinson’s Disease Market: Biomarker Movement Analysis
4.3. Blood-based Biomarker For Parkinson’s Disease Market Size & Trend Analysis, by Biomarker, 2021 to 2033 (USD Million)
4.4. Protein biomarkers
4.4.1. Protein biomarkers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Inflammatory markers
4.5.1. Inflammatory markers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Metabolic markers
4.6.1. Metabolic markers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Transcriptomic/miRNA
4.7.1. Transcriptomic/miRNA Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Others
4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Blood-based Biomarker For Parkinson’s Disease Market: Animal Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Blood-based Biomarker For Parkinson’s Disease Market: Animal type Movement Analysis
5.3. Blood-based Biomarker For Parkinson’s Disease Market Size & Trend Analysis, by animal type, 2021 to 2033 (USD Million)
5.4. Dogs
5.4.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Cats
5.5.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Horses
5.6.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Blood-based Biomarker for Parkinson’s Disease Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Blood-based Biomarker for Parkinson’s Disease Market: Technology Movement Analysis
6.3. Blood-based Biomarker for Parkinson’s Disease Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. ELISA/Immunoassay
6.4.1. ELISA/Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Multiplex platforms
6.5.1. Multiplex platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. NGS/qPCR (genetic)
6.6.1. NGS/qPCR (genetic) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Mass spectrometry
6.7.1. Mass spectrometry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Blood-based Biomarker for Parkinson’s Disease Market: By End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Blood-based Biomarker for Parkinson’s Disease Market: By End Use Movement Analysis
7.3. Blood-based Biomarker for Parkinson’s Disease Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.3.1. Academic/Research Labs
7.3.1.1. Academic/Research Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. Pharmaceutical / Biotech
7.3.2.1. Pharmaceutical / Biotech Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Hospitals
7.3.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Clinical Diagnostic Labs
7.3.4.1. Clinical Diagnostic Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.5. Others
7.3.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Blood-based Biomarker for Parkinson’s Disease Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Blood-based Biomarker for Parkinson’s Disease Market Share, By Region, 2024 & 2033 (USD Million)
8.3. Regional Outlook
8.4. North America
8.4.1. North America Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. U.S. Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. Canada Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Mexico Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5. Europe
8.5.1. Europe Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. UK Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. Germany Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. France Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. Italy Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Spain Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Denmark Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Sweden Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Regulatory framework/ reimbursement structure
8.5.9.3. Competitive scenario
8.5.9.4. Norway Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Japan Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. China Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. India Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. Australia Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. South Korea Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Regulatory framework/ reimbursement structure
8.6.7.3. Competitive scenario
8.6.7.4. Thailand Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Brazil Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. Argentina Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. South Africa Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory framework/ reimbursement structure
8.8.3.3. Competitive scenario
8.8.3.4. Saudi Arabia Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory framework/ reimbursement structure
8.8.4.3. Competitive scenario
8.8.4.4. UAE Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory framework/ reimbursement structure
8.8.5.3. Competitive scenario
8.8.5.4. Kuwait Blood-based Biomarker For Parkinson’s Disease Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. IDEXX Laboratories, Inc.
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Abbott Laboratories
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. ACOBIOM
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Alseres Pharmaceuticals
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Banyan Biomarkers
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Bio-Rad Laboratories
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. DiaGenic ASA
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Johnson & Johnson
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Merck KGaA
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. QIAGEN
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.10.5. Quanterix
9.3.10.6. Participant’s Overview
9.3.10.7. Financial Performance
9.3.10.8. Product Benchmarking
9.3.10.9. Strategic Initiatives
9.3.10.10. Thermo Fisher Scientific
9.3.10.11. Participant’s Overview
9.3.10.12. Financial Performance
9.3.10.13. Product Benchmarking
9.3.10.14. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Product launch
9.4.4. Others
9.5. List of other key players
List of tables
Table 1 List of secondary sources
Table 2 Blood-based Biomarker For Parkinson’s Disease Market, by region, 2021 - 2033 (USD Million)
Table 3 Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 4 Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 5 Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 6 North America Blood-based Biomarker For Parkinson’s Disease Market, by country, 2021 - 2033 (USD Million)
Table 7 North America Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 8 North America Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 9 North America Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 10 U.S. Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 11 U.S. Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 12 U.S. Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 13 Canada Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 14 Canada Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 15 Canada Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 16 Mexico Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 17 Mexico Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 18 Mexico Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 19 Europe Blood-based Biomarker For Parkinson’s Disease Market, by country, 2021 - 2033 (USD Million)
Table 20 Europe Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 21 Europe Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 22 Europe Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 23 Germany Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 24 Germany Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 25 Germany Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 26 UK Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 27 UK Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 28 UK Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 29 France Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 30 France Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 31 France Blood-based Biomarker For Parkinson’s Disease Market, by Type, 2021 - 2033 (USD Million)
Table 32 Italy Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 33 Italy Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 34 Italy Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 35 Spain Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 36 Spain Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 37 Spain Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 38 Denmark Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 39 Denmark Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 40 Sweden Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 41 Sweden Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 42 Sweden Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 43 Norway Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 44 Norway Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 45 Norway Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 46 Asia Pacific Blood-based Biomarker For Parkinson’s Disease Market, by country, 2021 - 2033 (USD Million)
Table 47 Asia Pacific Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 48 Asia Pacific Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 49 Asia Pacific Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 50 China Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 51 China Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 52 China Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 53 Japan Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 54 Japan Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 55 Japan Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 56 India Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 57 India Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 58 India Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 59 South Korea Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 60 South Korea Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 61 South Korea Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 62 Australia Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 63 Australia Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 64 Australia Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 65 Thailand Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 66 Thailand Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 67 Thailand Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 68 Latin America Blood-based Biomarker For Parkinson’s Disease Market, by country, 2021 - 2033 (USD Million)
Table 69 Latin America Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 70 Latin America Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 71 Latin America Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 72 Brazil Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 73 Brazil Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 74 Brazil Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 75 Argentina Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 76 Argentina Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 77 Argentina Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 78 MEA Blood-based Biomarker For Parkinson’s Disease Market, by country, 2021 - 2033 (USD Million)
Table 79 MEA Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 80 MEA Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 81 MEA Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 82 South Africa Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 83 South Africa Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 84 South Africa Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 85 Saudi Arabia Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 86 Saudi Arabia Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 88 UAE Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 89 UAE Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 90 UAE Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 91 Kuwait Blood-based Biomarker For Parkinson’s Disease Market, by Biomarker, 2021 - 2033 (USD Million)
Table 92 Kuwait Blood-based Biomarker For Parkinson’s Disease Market, by Technology, 2021 - 2033 (USD Million)
Table 93 Kuwait Blood-based Biomarker For Parkinson’s Disease Market, by End Use, 2021 - 2033 (USD Million)
Table 94 Company Overview
Table 95 Product Benchmarking
Table 96 Financial Performance
Table 97 Strategic Initiatives
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Blood-based Biomarker For Parkinson’s Disease Market revenue, 2021-2033 (USD Million)
Fig. 10 Blood-based Biomarker For Parkinson’s Disease Market snapshot
Fig. 11 Blood-based Biomarker For Parkinson’s Disease Market driver impact
Fig. 12 Blood-based Biomarker For Parkinson’s Disease Market restraint impact
Fig. 13 Blood-based Biomarker For Parkinson’s Disease biomarker key takeaways (USD Million)
Fig. 14 Blood-based Biomarker For Parkinson’s Disease Market: biomarker movement analysis
Fig. 15 Protein biomarkers market, 2021 - 2033 (USD Million)
Fig. 16 Inflammatory markers market, 2021 - 2033 (USD Million)
Fig. 17 Metabolic markers market, 2021 - 2033 (USD Million)
Fig. 18 Transcriptomic/miRNA market, 2021 - 2033 (USD Million)
Fig. 19 Others market, 2021 - 2033 (USD Million)
Fig. 20 Blood-based Biomarker For Parkinson’s Disease technology key takeaways (USD Million)
Fig. 21 Blood-based Biomarker For Parkinson’s Disease Market: technology movement analysis
Fig. 22 ELISA/Immunoassay market, 2021 - 2033 (USD Million)
Fig. 23 Multiplex platforms market, 2021 - 2033 (USD Million)
Fig. 24 NGS/qPCR (genetic) market, 2021 - 2033 (USD Million)
Fig. 25 Mass spectrometry market, 2021 - 2033 (USD Million)
Fig. 26 Others market, 2021 - 2033 (USD Million)
Fig. 27 Blood-based Biomarker For Parkinson’s Disease Market by End Use key takeaways (USD Million)
Fig. 28 Blood-based Biomarker For Parkinson’s Disease Market: by End Use movement analysis
Fig. 29 Academic/Research Labs market, 2021 - 2033 (USD Million)
Fig. 30 Pharmaceutical /Biotech market, 2021 - 2033 (USD Million)
Fig. 31 Hospitals market, 2021 - 2033 (USD Million)
Fig. 32 Clinical Diagnostic Labs market, 2021 - 2033 (USD Million)
Fig. 33 Others market, 2021 - 2033 (USD Million)
Fig. 34 Regional market place: Key takeaways
Fig. 35 Regional outlook, 2024 & 2033
Fig. 36 North America Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 37 U.S. Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 38 Canada Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 39 Mexico Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 40 Europe Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 41 UK Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 42 Germany Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 43 France Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 44 Italy Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 45 Spain Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 46 Denmark Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 47 Sweden Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 48 Norway Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 49 Asia Pacific Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 50 Japan Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 51 China Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 52 India Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 53 Australia Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 54 South Korea Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 55 Thailand Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 56 Latin America Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 57 Brazil Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 58 Argentina Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 59 MEA Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 60 South Africa Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 61 Saudi Arabia Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 62 UAE Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 63 Kuwait Blood-based Biomarker For Parkinson’s Disease Market, 2021 - 2033 (USD Million)
Fig. 64 Market participant categorization

Companies Mentioned

  • Abbott
  • ACOBIOM
  • Alseres Pharmaceuticals
  • Banyan Biomarkers
  • Bio-Rad Laboratories
  • DiaGenic ASA
  • Johnson & Johnson Services
  • Merck KGaA
  • QIAGEN
  • Quanterix
  • Rules-Based Medicine
  • Thermo Fisher Scientific

Related Topics

Related Reports

U.S. Blood-based Biomarker For Parkinson's Disease Market Size, Share & Trends Analysis Report By Biomarker Type (Protein Biomarkers, Inflammatory Markers), By Technology (ELISA/Immunoassay, Multiplex Platforms), By End Use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Blood-based Biomarker For Parkinson's Disease Market Size, Share & Trends Analysis Report By Biomarker Type (Protein Biomarkers, Inflammatory Markers), By Technology (ELISA/Immunoassay, Multiplex Platforms), By End Use, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • United States
From
Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 134 Pages
  • Global
From
Biomarkers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Biomarkers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Biomarkers (Genetic v/s Protein), By Sample (Blood Based v/s Non-Blood-Based), By Technology, By Application, By End User, By Company and By Region - Product Image

Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Biomarkers (Genetic v/s Protein), By Sample (Blood Based v/s Non-Blood-Based), By Technology, By Application, By End User, By Company and By Region

  • Report
  • 115 Pages
  • Global
From
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report - Product Image

Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.